These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17013638)

  • 21. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.
    Riga MS; Soria G; Tudela R; Artigas F; Celada P
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1269-82. PubMed ID: 24650558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.
    Krebs-Thomson K; Paulus MP; Geyer MA
    Neuropsychopharmacology; 1998 May; 18(5):339-51. PubMed ID: 9536447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.
    Halberstadt AL; Lehmann-Masten VD; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2011 May; 215(1):81-92. PubMed ID: 21153406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
    Fantegrossi WE; Reissig CJ; Katz EB; Yarosh HL; Rice KC; Winter JC
    Pharmacol Biochem Behav; 2008 Jan; 88(3):358-65. PubMed ID: 17905422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of the behavioral effects of morphine in rats by serotonin 5-HT₁A and 5-HT₂A receptor agonists: antinociception, drug discrimination, and locomotor activity.
    Li JX; Shah AP; Patel SK; Rice KC; France CP
    Psychopharmacology (Berl); 2013 Feb; 225(4):791-801. PubMed ID: 22993050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
    Varty GB; Bakshi VP; Geyer MA
    Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.
    Powell SB; Palomo J; Carasso BS; Bakshi VP; Geyer MA
    Psychopharmacology (Berl); 2005 Jul; 180(3):491-500. PubMed ID: 15719216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
    Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
    Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus.
    Adams W; van den Buuse M
    Neuropharmacology; 2011 Sep; 61(3):458-67. PubMed ID: 21477601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties.
    Puigseslloses P; Nadal-Gratacós N; Ketsela G; Weiss N; Berzosa X; Estrada-Tejedor R; Islam MN; Holy M; Niello M; Pubill D; Camarasa J; Escubedo E; Sitte HH; López-Arnau R
    Mol Psychiatry; 2024 Aug; 29(8):2346-2358. PubMed ID: 38486047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
    Fletcher PJ; Grottick AJ; Higgins GA
    Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
    Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum.
    Sipes TE; Geyer MA
    Brain Res; 1997 Jun; 761(1):97-104. PubMed ID: 9247071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.
    Shen HW; Jiang XL; Winter JC; Yu AM
    Curr Drug Metab; 2010 Oct; 11(8):659-66. PubMed ID: 20942780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A narrative synthesis of research with 5-MeO-DMT.
    Ermakova AO; Dunbar F; Rucker J; Johnson MW
    J Psychopharmacol; 2022 Mar; 36(3):273-294. PubMed ID: 34666554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
    Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD.
    Young R; Rosecrans JA; Glennon RA
    Life Sci; 1982 Jun; 30(24):2057-62. PubMed ID: 7109835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.